Source comparison
TB-500 vs Corticosteroid Injection: Mechanism Comparison
TB-500 (Thymosin Beta-4) Binds G-actin to promote cell migration, upregulates VEGF for angiogenesis, enhances collagen fiber alignment Structural repair. Increases collagen type I deposition, improves tensile strength, reduces scar tissue Preclinical (animal m
This comparison does not assign a generated winner or score.
- TB-500 (Thymosin Beta-4)
- Binds G-actin to promote cell migration, upregulates VEGF for angiogenesis, enhances collagen fiber alignment
- Structural repair. Increases collagen type I deposition, improves tensile strength, reduces scar tissue
- Preclinical (animal models) strong; human data limited to case series
- 6–12 weeks for measurable tissue remodelling
- Addresses root pathology but lacks FDA approval and large-scale human trial validation in 2026
- Corticosteroid Injection
- Suppresses prostaglandin synthesis via COX inhibition, reduces inflammatory cell infiltration
- Symptom suppression. Reduces pain and swelling without repairing tendon microstructure
- Strong short-term (<6 weeks); long-term outcomes worse than placebo in multiple RCTs
- 1–4 weeks for peak symptom relief
- Rapid symptom control but may impair healing and increase re-injury risk with repeated use
- Platelet-Rich Plasma (PRP)
- Delivers growth factors (PDGF, TGF-β, IGF-1) to injury site via concentrated autologous platelets
- Variable. Growth factor release theoretically promotes healing but preparation protocols lack standardisation
- Mixed. Meta-analyses show modest benefit over placebo, high heterogeneity between studies
- 8–16 weeks for functional improvement
- Biologics-based but inconsistent outcomes due to preparation variability
- Rest + Physical Therapy
- Reduces mechanical load, eccentric exercises promote collagen remodelling through controlled loading
- Functional adaptation. Strengthens surrounding musculature, improves biomechanics
- Strong. Cochrane reviews support eccentric exercise protocols as first-line treatment
- 12–24 weeks for full symptom resolution
- Evidence-based standard of care but requires patient compliance and extended timelines